Molecular mechanism of an antagonistic antibody against glucose-dependent insulinotropic polypeptide receptor

Glucose-dependent insulinotropic polypeptide (GIP) is an incretin hormone involved in regulating glucose and lipid metabolism. GIP receptor (GIPR) antagonism is believed to offer therapeutic potential for various metabolic diseases. Pharmacological intervention of GIPR, however, has limited success...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Xiaoshan, Yie, Junming, Wang, Jinghong, Chung, Ben C., Huang, Ching-Shin, Xu, Haoda, Yang, Jie, Deng, Liying, Lin, Joanne, Chen, Qing, Abbott, Christina M., Gundel, Caroline, Thibault, Stephen A., Meng, Tina, Bates, Darren L., Lloyd, David J., Véniant, Murielle M., Wang, Zhulun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973313/
https://www.ncbi.nlm.nih.gov/pubmed/31905038
http://dx.doi.org/10.1080/19420862.2019.1710047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973313/
https://www.ncbi.nlm.nih.gov/pubmed/31905038
http://dx.doi.org/10.1080/19420862.2019.1710047

Ejemplares similares